Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03152929 · ClinicalTrials.gov registry record · Phase 3

Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC)

A Phase 3 study, sponsored by Corewell Health West.

Terminated
Registry status
Phase 3
Development phase
89
Enrollment target

NCT03152929 is a Phase 3 study that was terminated before completion, run by Corewell Health West. The registered enrollment target is 89 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03152929, a Phase 3 study, was terminated before completion, sponsored by Corewell Health West.

TERMINATED
Registry status
Phase 3
Development phase
89 participants
Enrollment target

Study Summary

The purpose of this study is to compare two standard methods of pain control management used at Spectrum Health for patients undergoing breast surgery. The two methods being compared are the paravertebral block (PVB) and the pectoral nerve block (PEC). Postoperative pain control is essential following any major operative procedure. A variety of methods have been used to ensure adequate pain control, each with its own advantages and risks. Increasingly, attention has focused on regional methods of analgesia, which may allow for reduction in systemic narcotic use and their associated complications. Proposed benefits of regional analgesia and a resultant reduction in narcotic use include decreased risk of cancer progression, decreased length of stay, and decreased risk of ileus.

Interventions

  • DRUG Paravertebral Block
  • DRUG Pectoral Nerve Block

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2017-03-09
Est. Completion 2019-05-21
Phase Phase 3

Sponsor

Corewell Health West

38 total trials

What the Registry Record Tells You About NCT03152929

The ClinicalTrials.gov registry entry for NCT03152929 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Paravertebral Block is the first listed.

NCT03152929 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03152929 about?

NCT03152929 is a clinical study titled "Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC)". The purpose of this study is to compare two standard methods of pain control management used at Spectrum Health for patients undergoing breast surgery. The two methods being compared are the paravertebral block (PVB) and the pectoral nerve block (PEC). Postoperative pain control is essential followi...

What is the current status of trial NCT03152929?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 89 participants. The study started on 2017-03-09. Estimated completion is 2019-05-21.

What interventions are being tested in trial NCT03152929?

The interventions under investigation include: Paravertebral Block (DRUG), Pectoral Nerve Block (DRUG).

Who is sponsoring clinical trial NCT03152929?

This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.